Perkins Capital Management Inc: Q3 2022 vs. Q4 2022 13F Holdings Analysis

Perkins Capital Management Inc., a registered investment advisor, filed its Q4 2022 13F with the SEC recently. The company manages over $400 million in assets and specializes in small-cap value investing. The Q4 13F filing shows a comparison of its portfolio holdings to the previous quarter.

In this blog post, we will analyze the changes in Perkins Capital Management's portfolio holdings, focusing on the top 10 positions that saw the most significant changes in terms of percentage.

LLY - Lilly Eli & Co

Perkins Capital Management maintained its position in Lilly Eli & Co with 13,216 shares worth $4,835,000, a 13.2% increase in value from the previous quarter.

IDXX - Idexx Labs Inc

Perkins Capital Management increased its position in Idexx Labs Inc by 25.2%, holding 10,805 shares worth $4,408,000.

DGII - Digi Intl Inc

Perkins Capital Management decreased its position in Digi Intl Inc by 4.2%, holding 110,433 shares worth $3,980,000.

MSFT - Microsoft Corp

Perkins Capital Management maintained its position in Microsoft Corp with 15,326 shares worth $3,675,000, a 3% increase in value from Q3 2022.

AXGN - Axogen Inc

Perkins Capital Management decreased its position in Axogen Inc by 16.2%, holding 306,640 shares worth $3,064,000.

VCYT - Veracyte Inc

Perkins Capital Management increased its position in Veracyte Inc by 42.4%, holding 123,530 shares worth $2,920,000.

ABT - Abbott Labs Inc

Perkins Capital Management decreased its position in Abbott Labs Inc by 11.3%, holding 26,980 shares worth $2,907,000.

PERI - Perion Network Ltd

Perkins Capital Management increased its position in Perion Network Ltd by 30.9%, holding 106,721 shares worth $2,696,000.

AUGX - Augmedix Inc

Perkins Capital Management increased its position in Augmedix Inc by 304.5%, holding 1,680,428 shares worth $2,621,000.

PFE - Pfizer Inc

Perkins Capital Management decreased its position in Pfizer Inc by 15.3%, holding 51,216 shares worth $2,583,000.

Conclusion

In conclusion, Perkins Capital Management's Q4 2022 13F filing shows a mixed bag of changes in its top holdings. While some positions saw significant increases, others saw decreases. It's important to note that these are just the top 10 holdings and that Perkins Capital Management's entire portfolio may have undergone further changes.

Investors looking to invest in small-cap value strategies may find Perkins Capital Management's investment approach attractive. However, before investing, it's crucial to conduct thorough research on the investment firm and its holdings.